• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Interventional Radiologists: Y-90 Liver Cancer Treatment Effective

Article

Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results were chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be effective and help preserve the patient’s quality of life, according to a study presented this week at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.

Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results where chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be effective and help preserve the patient’s quality of life, according to a study presented this week at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.

"We knew that this unique interventional radiology treatment, done on an outpatient basis, which combines the radioactive isotope Y-90 into microspheres (small beads about the width of five red blood cells) that deliver radiation directly to a tumor, was one of the best ways to give patients a treatment that doesn't harm healthy cells," Riad Salem, MD, MBA, FSIR, professor of radiology, medicine, and surgery, and director of interventional oncology at Northwestern University’s radiology department, said in a statement.

"Now we know that patients can actually tolerate much higher doses of radiation than previously thought, which provides results in patients progressing on standard chemotherapy," he said.

Patients aren’t cured, but their lives are being extended and quality of life improved, he said.

In the four-year study, researchers looked at 151 patients with liver metastases from colorectal, neuroendocrine, and other cancers. Surgical removal of liver tumors is the best option, Salem said, but most patients aren’t candidates, and chemo becomes less effective as the disease progresses. In this study, patients showed high rates of “progression-free survival,” reasearchers said.

Here’s how the Y-90 radioembolization treatment works. The microspheres are injected through a catheter from the groin, and the beads become lodged within the tumor vessels where they cause cell death. This technique allows for a higher, local dose of radiation, with no danger from radiation to the healthy tissue in the body, according to Salem.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.